Results 41 to 50 of about 349,758 (166)

Which patients are prone to suffer liver metastasis? A review of risk factors of metachronous liver metastasis of colorectal cancer

open access: yesEuropean Journal of Medical Research, 2022
Background In recent years, with the increasing incidence of colorectal cancer (CRC) and its high fatality rate, CRC has seized the attention of the world. And liver metastasis, as the main cause of death of CRC, has become the leading cause of treatment
Mengdi Hao   +5 more
doaj   +1 more source

miRNA biomarkers in colon cancer liver metastasis: a preliminary analysis

open access: yes结直肠肛门外科, 2022
[Objectives] To identify miRNAs associated with colon cancer liver metastasis and their influences on survival. [Methods] The study compared the miRNAs data sets of primary colon cancer tissues and liver metastasis tissues from colon cancer patients with
Fu Tianhao   +8 more
doaj   +1 more source

Differential expression of PLAC1 and Netrin-1 in liver metastasis of colorectal cancer and its predictive value

open access: yesBMC Gastroenterology, 2023
Objective To explore the differential expression of placental specific gene 1 (PLAC1) and neurite guidance factor 1 (netrin-1) in colorectal cancer (CRC) liver metastasis and its predictive value.
Zhijun Wang   +3 more
doaj   +1 more source

Based on SEER Database: Population Distribution, Survival Analysis, and Prognostic Factors of Organ Metastasis of Lung Large Cell Neuroendocrine Carcinoma

open access: yesFrontiers in Oncology, 2022
BackgroundThe incidence rate of lung large cell neuroendocrine carcinoma (LCNEC) in lung cancer is low, but the malignancy is high and the prognosis is poor.
Chang-fu Liu, Yu-jian Tao
doaj   +1 more source

Carcinoid syndrome without liver metastasis [PDF]

open access: yesPostgraduate Medical Journal, 1989
Summary The carcinoid syndrome generally occurs due to metastasis of a carcinoid tumour in the liver. A patient is presented who had carcinoid syndrome due to abdominal disease without hepatic metastasis.
J, Hossain   +3 more
openaire   +2 more sources

Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma

open access: yesClinical Epigenetics
The 5-methylcytosine (m5C) post-transcriptional modification has been linked with the development and progression of a variety of cancers. However, its specific functions and their underlying mechanisms are poorly understood in hepatocellular carcinoma ...
Xuhui Zhao   +18 more
doaj   +1 more source

Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma

open access: yesJournal of Hematology & Oncology, 2021
Background Metastasis occurs in the majority of pancreatic ductal adenocarcinoma (PDAC) patients at diagnosis or following resection. Patients with liver metastasis and those with lung metastasis have significantly different prognosis. Here, we sought to
Xingyi Pan   +7 more
doaj   +1 more source

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

open access: yesCancer Medicine, 2018
The hematogenous metastatic pattern of gastric cancer (GC) was not fully explored. Here we analyzed the frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from GC patients.
Miao‐Zhen Qiu   +12 more
doaj   +1 more source

Metachronous liver metastasis after curative gastrectomy for gastric adenocarcinoma [PDF]

open access: yesKorean Journal of Clinical Oncology, 2014
Purpose: The prognosis of patients with liver metastasis from gastric cancer is poor and the optimal treatment remains undetermined. This study identified prognostic factors for survival of patients with metachronous liver metastasis with no other ...
Suk-Hyun Shin   +8 more
doaj   +1 more source

Gastric cancer with liver metastasis

open access: yesBratislava Medical Journal, 2016
Surgical treatment of gastric cancer with liver metastasis (GCLM) is currently a frequent topic of discussion at professional surgical symposia. There is a low number of patients and a lack of large clinical multi-center studies describing the benefits of this treatment approach.
V, Marek   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy